Oedien (Dienogest, Ethinylestradiol | Lactose Monohydrate)

Dienogest is a synthetic progestogen that binds to progesterone receptors, inhibiting the growth of endometrial tissue and suppressing ovulation. When paired with ethinylestradiol, the formulation stabilises the endometrium and provides estrogenic support, together regulating the menstrual cycle and reducing ectopic endometrial lesions.

The dosage of Oedien is determined by the prescribing clinician based on the patient’s medical history and therapeutic goals. The prescriber selects the appropriate regimen and provides detailed instructions for daily oral administration.

Oedien is contraindicated during pregnancy because it is intended to prevent conception. If pregnancy occurs, the product should be discontinued immediately. Limited data are available for breastfeeding; clinicians usually advise against use while nursing unless the benefits outweigh potential risks.

To request Oedien, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Oedien combines dienogest, a progestogen with strong anti‑endometriotic activity, with ethinylestradiol. Compared with many other combined oral contraceptives that use levonorgestrel or desogestrel, Oedien may offer superior relief of endometriosis‑related pain while providing reliable contraception, though individual response varies.

Oedien tablets should be stored at ambient temperature, below 25 °C, in the original blister pack. Protect the product from excess moisture, heat and direct sunlight to maintain potency throughout its shelf life.

Oedien is taken orally, once daily, at the same time each day. The tablet is swallowed with water and should be taken with or without food, following the prescriber’s instructions regarding the start of the cycle.

Serious risks include venous thromboembolism (blood clots), hypertension, severe liver dysfunction and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like sudden leg swelling, chest pain, severe abdominal pain, jaundice or difficulty breathing.

Oedien is contraindicated in women who are pregnant, have a known or suspected hormone‑sensitive cancer, have uncontrolled hypertension, a history of thromboembolic disorders, liver disease, or who smoke and are over 35 years of age. A thorough medical evaluation is required before initiating therapy.